[ Pharmaceutical Sciences Asia - ONLINE ]
E-ISSN 2586-8470
[ Journal Abbreviation: Pharm.Sci.Asia ]
Mahidol University Journal of Pharmaceutical Sciences
  FORMER NAME   "Mahidol University Journal of Pharmaceutical Sciences" Published Since 1974

 
Abstracts

DOI: 10.29090/psa.2025.01.24.1659Pharm Sci Asia 2025; 52(1), 11-29
 

Unveiling Potential Therapeutic Targets for Colon Cancer: A Comprehensive Bioinformatics Analysis of miRNA-Mediated Regulation

Fachrur Rizal Mahendra1,2, Gusnia Meilin Gholam1,2, Muhammad Musthofa1, Muhammad Marsha Azzami Hasibuan1, Akbar Rafiqi1, Hafizh Zahra1, Rahadian Pratama1, Laksmi Ambarsari1, I Made Artika1, Waras Nurcholis1,3,*

1 Department of Biochemistry, Faculty of Mathematics and Natural Sciences, Bogor 8 Agricultural University, Bogor 16680, Indonesia
2 Bioinformatics Research Center, Indonesian Institute of Bioinformatics (INBIO), Malang, 10 Indonesia
3 Tropical Biopharmaca Research Center, Bogor Agricultural University, Kampus IPB Taman 12 Kencana, Bogor, 16128, Jawa Barat, Indonesia


Cancer remains a significant health challenge in Asia, with lung, breast, and colorectal cancers ranking among the most prevalent and lethal. Colon cancer, when detected early, offers the prospect of successful treatment; however, late-stage diagnosis often limits curative interventions. Recent advances have proposed microRNAs (miRNAs) as promising elements in cancer therapy, acting as either tumor suppressor genes or inhibitors of oncogenic miRNAs. This study employed topology and centrality analyses to identify pivotal genes in colon cancer and explore dysregulated miRNAs with high binding probability to their target proteins. This investigation extends to the assessment of miRNA-mRNA interactions and duplex complexes with argonaute (AGO) proteins, shedding light on potential therapeutic avenues. Notably, our bioinformatics predictions potential upregulated genes in colon cancer of Asia population such CAV1, KLF4, and TAGLN and the potential of miRNA suppressing these genes are hsa-miR-429, hsa-miR-200c, and hsa-miR-22 respectively, as robust candidates for suppressing oncogene expression in colon cancer. Detailed scrutiny of the binding affinity, conformation, and conformational stability through molecular dynamics enhances the precision of these findings. This study provides valuable insights into the selection of optimal miRNA candidates for targeted utilization in colon cancer therapy.


Keyword:

Colon Cancer; miRNA; Network Analysis; In silico




Download full paper (PDF File size: 1,702.48 KB.)





Vol.52
No.1
January-March 2025

See other volume

 
 
 

Home
Aims and Scope
Editorial Board
Publication Ethics
Instruction to Authors
Announcement
All Volumes & Issues
Submit Online
Contact us
   
Search
   
Faculty of Pharmacy Mahidol University
Mahidol University



Pharmaceutical Sciences Asia by Faculty of Pharmacy, Mahidol University, Thailand is licensed under CC BY-NC-ND 4.0

    Copyright © 2017-2025
    Faculty of Pharmacy, Mahidol University, THAILAND
 

We use Cookies

This site uses cookies to personalise your experience and analyse site traffic. By Clicking ACCEPT or continuing to browse the site you are agreeing to our use of cookies.